GREENFIELD, Ind. (January 10, 2016)-- Elanco Animal Health, a division of Eli Lilly and Company, has launched Itrafungol ™ (
itraconazole oral solution), the only marketed FDA - approved * systemic treatment for dermatophytosis (ringworm) caused by Microsporum canis in cats.
Elanco Animal Health, a division of Eli Lilly and Company, has launched Itrafungol ™ (
itraconazole oral solution), the only marketed FDA - approved * systemic treatment for dermatophytosis (ringworm) caused by Microsporum canis in cats.